Comparison of treatment outcome with a full-occlusion biofeedback splint on sleep bruxism and TMD pain compared to treatment with an adjusted occlusal splint

Comparison of treatment outcome with a full-occlusion biofeedback splint on sleep bruxism and TMD pain compared to treatment with an adjusted occlusal splint - biofeedback study bruxism

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00018092

Enrollment

Registered

2020-05-06

Start date

2015-10-08

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F45.8

Interventions

Group 1: test group: biofeedback splint therapy and questionnaires Group 2: control group: adjusted occlusal splint therapy and questionnaires

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) physical signs of bruxism visible on the dentition (grinding facets, abnormal tooth wear and/or wedge-shaped lesions) (2) self-reported pain in the masticatory muscles and/or the temporomandibular joint (“TMJ”) (3) willingness of the patient to participate in the study and a commitment to adhere to the pre-set timetable.

Exclusion criteria

Exclusion criteria: (1) acute pain caused by other components of the masticatory system (e.g. caries, root inflammation) (2) prior or planned TMJ or dysgnathia surgery (3) jaw fractures, (4) otorhinolaryngologic diseases (except tinnitus), (5) systemic basic illness with rheumatic origin e.g. arthritis, arthrosis, gout and psoriasis, (6) psychosomatic or psychiatric diseases, (7) implanted electronic devices, (8) arrhythmia and other (prior or present) cardiac problems, (9) epilepsy, (10) cerebrovascular and brain diseases, (11) pregnancy including breastfeeding period, (12) drug or alcohol abuse, analgesic or sedative therapy, use of medication affecting the central nervous system (e.g. antidepressants, anxiolytics and anticonvulsants), (13) physical or mental disability, (14) maxillary hyperesthesia and/or allergy to materials used, (15) missing support zones in the posterior region or anatomical topography which made a full-coverage maxillary splint impossible to use, (16) a past history of received biofeedback therapy and (17) insufficient recorded bruxing activity in the baseline phase

Design outcomes

Primary

Measure	Time frame
Recording of bruxism activity 2018	—

Secondary

Measure	Time frame
Aquisition of questionnaire and clinical examination 2018	—

Countries

Germany

Contacts

Public ContactAlexander Bergmann

Poliklinik für Zahnärztliche Prothetik

alexander.bergmann@med.uni-muenchen.de+4989440059501

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 18, 2026